Advertisements

Stocking Stuffers

 

Aptose Biosciences Inc. (APS:CA) Stock Quote

Detailed Quote for Aptose Biosciences Inc. (APS:CA)
$ 2.64   0.03 (+1.15%) Volume: 1.31k 9:44 AM EDT Mar 18, 2019
Today 5d 1m 3m 1y more
Last Price
2.64
Change $
0.03
Change %
1.15%
Tick
  
Bid
2.63
Bid Size
300
Ask
2.65
Ask Size
300
Open
2.61
High
2.64
Low
2.60
Prev Close
2.61
Last Trade
9:44
Volume
1.31k
52 Wk Hi
5.96999979
52 Wk Low
2.07999992
Market Cap
103.53m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
39,215,348
EPS (TTM)
-1.14999997
PE Ratio
N/A
Exchange
TSX
News and Media for Aptose Biosciences Inc. (APS:CA)
Sector News | Topic News
News for Aptose Biosciences Inc. (APS:CA)
Tue, Mar 12, 2019
4:02 PM Aptose Reports Results for the Fourth Quarter and Year Ended December 31, 2018 - GlobeNewswire
Thu, Mar 07, 2019
7:00 AM Aptose to Participate in Upcoming Investor Conferences in March 2019 - GlobeNewswire
Mon, Mar 04, 2019
7:00 AM Aptose Biosciences and CrystalGenomics Announce Issuance of Australian Patent for CG-806 - GlobeNewswire
Thu, Feb 28, 2019
7:00 AM Aptose to Present New CG-806 and APTO-253 Data at the 2019 AACR Annual Meeting - GlobeNewswire
Tue, Feb 26, 2019
7:30 AM Aptose To Release Fourth Quarter and Year End December 31, 2018 Financial Results and Hold Conference Call on March 12, 2019 - GlobeNewswire
Mon, Feb 25, 2019
7:00 AM Aptose Biosciences Submits IND Application for CG-806 - GlobeNewswire
Tue, Feb 19, 2019
7:30 AM Aptose to Present at the 8th Annual SVB Leerink Global Healthcare Conference - GlobeNewswire
Mon, Jan 28, 2019
7:45 AM Today's Research Reports on Oncolytics Biotech, Delivra, Aptose Biosciences and ProMIS Neurosciences - ACCESSWIRE IA
Wed, Jan 02, 2019
7:05 AM Aptose Biosciences to Present at Biotech Showcase(TM) 2019 Conference - GlobeNewswire
Tue, Dec 18, 2018
7:45 AM Today's Research Reports on Aptose Biosciences, ProMIS Neurosciences, Emblem and BELLUS Health - ACCESSWIRE IA
Wed, Dec 12, 2018
10:00 AM Aptose Presents Highlights From CG-806 KOL Event - GlobeNewswire
Mon, Dec 03, 2018
7:10 AM OHSU and Aptose Present New CG-806 Preclinical Data at ASH 60th Annual Meeting - GlobeNewswire
7:05 AM Aptose Presents New Preclinical Data on CG-806 PAN-FLT3/PAN-BTK Inhibitor at ASH 60th Annual Meeting - GlobeNewswire
Mon, Nov 26, 2018
7:05 AM Aptose Biosciences Doses First Patient in Re-Initiation of Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Malignancies - GlobeNewswire
Tue, Nov 20, 2018
7:05 AM Aptose to Participate in Upcoming Investor Conferences, Host Key Opinion Leader Event, and Present Data at the Upcoming ASH Meeting - GlobeNewswire
Tue, Nov 06, 2018
4:05 PM Aptose Reports Results for the Third Quarter Ended September 30, 2018 - GlobeNewswire
Thu, Nov 01, 2018
9:26 AM Aptose to Present New CG-806 Data at the 2018 ASH Annual Meeting - GlobeNewswire
Tue, Oct 23, 2018
7:05 AM Aptose to Release Third Quarter Ended September 30, 2018 Financial Results on November 6, 2018 - GlobeNewswire
Fri, Oct 05, 2018
8:00 AM Today's Research Reports on ESSA Pharma, Oncolytics Biotech, Aptose Biosciences and OrganiGram - ACCESSWIRE IA
Thu, Sep 27, 2018
7:05 AM Aptose Biosciences and CrystalGenomics Announce Issuance of European Patent for CG-806 - GlobeNewswire
More News for APS:CA >>

Tags for Aptose Biosciences Inc.

Research stocks or mutual funds related to Aptose Biosciences Inc. by keywords or tags. Find companies that have a similar focus to APS:CA. The keywords below have been associated to APS:CA by either user submission or electronic means.

Miscellaneous Intermediation (523910) Common Stock Venture Capital Companies (7125) Financial Services Financial